Recombinant Human GAMT Protein，His

GAMT (Guanosine monophosphate activation enzyme) is a critical enzyme involved in the biosynthesis of creatine, which plays a vital role in energy metabolism within muscle and brain tissues. The significance of GAMT is underscored by its involvement in the creatine biosynthesis pathway, where it catalyzes the conversion of guanidinoacetate and ATP into creatine and AMP. Deficiencies in GAMT can lead to severe neurological disorders, including GAMT deficiency, characterized by intellectual disability, seizures, and movement disorders due to compromised energy metabolism in the brain. Therefore, understanding GAMT's structure and function is crucial for development of therapeutic strategies. Recent advancements in recombinant protein technology have enabled the production of GAMT in heterologous systems, allowing for detailed functional studies and structural characterization. These efforts have facilitated the exploration of GAMT's enzymatic mechanisms, regulation, and potential as a drug target for metabolic diseases. Furthermore, recombinant GAMT could serve as a tool for therapeutic enzyme replacement in affected individuals, highlighting the enzyme's relevance in translational research and clinical applications. Understanding the biochemical properties and potential applications of GAMT can pave the way for innovations in treating energy metabolism disorders, ultimately contributing to improved health outcomes.